AIMT
Aimmune Therapeutics, Inc.
AIMT
AIMT
Delisted
AIMT was delisted on the 12th of October, 2020.
142 hedge funds and large institutions have $1.21B invested in Aimmune Therapeutics, Inc. in 2018 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 40 increasing their positions, 48 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
142
Holders Change
-9
Holders Change %
-5.96%
% of All Funds
3.25%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
20
Increased
40
Reduced
48
Closed
29
Calls
$14.9M
Puts
$3.37M
Net Calls
+$11.5M
Net Calls Change
+$8.52M
Top Buyers
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
$52.3M |
| 2 |
BlackRock
New York
|
$109M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
$14.1M |
| 4 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
$5.08M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$97.6M |
